St. Luke's University Health Network
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
2015 · Michael A. Postow, Jason Chesney, et al. · New England Journal of Medicine
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 · T. N. Walsh, N. Noonan, et al. · New England Journal of Medicine
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
2015 · Antoni Ribas, Igor Puzanov, et al. · The Lancet Oncology